Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

Robert G. Carson net worth and biography

Robert Carson Biography and Net Worth

SVP of Waters

Robert G. Carson, serves as Senior Vice President, Corporate Development in February 2018. Prior to joining Waters Corporation, he held several positions during his 16 years at Medtronic plc, including Vice President and General Manager, Pacemaker Business from January 2017 to January 2018. In addition, Mr. Carson spent nearly 12 years in Medtronic’s spinal implants and biologics business, serving as Vice President and General Manager from July 2016 to January 2017, Vice President of Global Marketing & Strategy from April 2015 to July 2016 and Vice President & Therapy Segment Leader from October 2012 to April 2015. Mr. Carson began his career with Banc of America Securities.

What is Robert G. Carson's net worth?: The estimated net worth of Robert G. Carson is at least $1.27 million as of November 12th, 2020. Mr. Carson owns 3,451 shares of Waters stock worth more than $1,270,520 as of December 22nd. This net worth approximation does not reflect any other investments that Mr. Carson may own. Learn More about Robert G. Carson's net worth.
How do I contact Robert G. Carson?: The corporate mailing address for Mr. Carson and other Waters executives is 34 MAPLE STREET, MILFORD MA, 01757. Waters can also be reached via phone at (508) 478-2000 and via email at [email protected]. Learn More on Robert G. Carson's contact information.
Has Robert G. Carson been buying or selling shares of Waters?: Robert G. Carson has not been actively trading shares of Waters over the course of the past ninety days. Most recently, Robert G. Carson sold 2,277 shares of the business's stock in a transaction on Thursday, November 12th. The shares were sold at an average price of $227.95, for a transaction totalling $519,042.15. Following the completion of the sale, the senior vice president now directly owns 3,451 shares of the company's stock, valued at $786,655.45. Learn More on Robert G. Carson's trading history.
Who are Waters' active insiders?: Waters' insider roster includes Linda Baddour (Director), Michael Berendt (Director), Sherry Buck (Former CFO), Robert Carson (SVP), Edward Conard (Director), Richard Fearon (Director), Michael Harrington (SVP), Ian King (SVP), Christopher Kuebler (Director), Christopher O'Connell (CEO), JoAnn Reed (Director), Thomas Salice (Director), and Mark Vergnano (Director). Learn More on Waters' active insiders.
Are insiders buying or selling shares of Waters?: During the last twelve months, Waters insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $332,900.00. During the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 4,500 shares worth more than $1,624,330.00. The most recent insider tranaction occured on May, 28th when Director Richard H Fearon bought 1,000 shares worth more than $332,900.00. Insiders at Waters own 0.8% of the company. Learn More about insider trades at Waters.
Information on this page was last updated on 5/28/2024.

Robert G. Carson Insider Trading History at Waters

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/12/2020	Sell	2,277	$227.95	$519,042.15	3,451
3/6/2019	Sell	2,724	$241.23	$657,110.52	3,898

Robert G. Carson Buying and Selling Activity at Waters

Waters Company Overview

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Today's Range

Now: $368.16

$357.84

$369.61

50 Day Range

MA: $367.26

$322.57

$392.01

2 Week Range

Now: $368.16

$279.24

$397.02

Volume

1,737,250 shs

Average Volume

447,060 shs

Market Capitalization

$21.86 billion

P/E Ratio

35.13

Dividend Yield

N/A

Beta

1.01

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.